ArticleOPEN ACCESS

Regulators' Advice Can Make a Difference: European Medicines Agency Approval of Zynteglo for Beta Thalassemia

Clinical Pharmacology and Therapeutics
DOI: 10.1002/cpt.1639
46Citations
Citations of this article
77Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Schuessler-Lenz, M., Enzmann, H., & Vamvakas, S. (2020, March 1). Regulators’ Advice Can Make a Difference: European Medicines Agency Approval of Zynteglo for Beta Thalassemia. Clinical Pharmacology and Therapeutics. Nature Publishing Group. https://doi.org/10.1002/cpt.1639

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free